Alnylam Pharmaceuticals | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 40.25M 1.6M 2025-06
Amgen USD 723M 24M 2025-03
Arrowhead Research USD 21.64M 7K 2025-03
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Incyte USD 594K 66K 2025-06
Ionis Pharmaceuticals USD 19M 0 2025-06
Moderna USD 1000K 0 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Sanofi 66.11M 20.67M 2024-12
Sarepta Therapeutics USD 4.5M 415K 2025-03
Takeda 107.16B 56.83B 2025-06
Tectonic Therapeutic USD 22K 3K 2024-12
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 3.7M 900K 2025-06
Xencor 8.66M 48.02M 2025-03


Alnylam Pharmaceuticals Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.